Mark Bloomfield joined Applied Biosystems as vice president of sales for molecular biology in Europe in November 2005, ABI said this week.
Bloomfield most recently was director of European commercial operations for the Scientific Instruments division of Thermo Electron. He has also served as aftermarket sales and sales development manager with Agilent Technologies Europe and European business development manager for mass spectrometry and gas phase chromatography with Hewlett-Packard.
Luminex announced the formation of a new scientific advisory board last week. It comprises Thomas Caskey, Ronald Bowsher, Andrea Ferreira-Gonzalez, Thomas Joos, and Gary Procop. The chairman of the new board is James Jacobson, vice president of R&D at Luminex.
Thomas Caskey is director of the Brown Foundation Institute of Molecular Medicine at the University of Texas Health Science Center. He has served as president of the American Society of Human Genetics, the Human Genome Organization, and the Academy of Medicine, Engineering and Science of Texas.
Ronald Bowsher is a partner of Bowsher Brunelle Smith and a fellow of the American Association of Pharmaceutical Sciences. He was at Lilly Research Labs until his retirement in 2003.
Ferreira-Gonzalez is a professor of pathology at Virginia Commonwealth University and director of the VCU molecular diagnostics lab. She has served as a member of the clinical laboratory improvement advisory committee at the US Department of Health and Human Services.
Joos is head of the biochemistry department of the NMI Institute at the University of Tubingen. He is a scientific advisor of BioChipNet and a member of the scientific advisory board of the Plasma Proteome Institute in Washington DC.
Procop is head of clinical microbiology at the Cleveland Clinic, which he joined in 1988. Prio to that he was pathology resident at Duke University Medical Center and at the Mayo Clinic.
Tepnel Diagnostics this week launched Elucigene QST*R, an assay based on quantitative fluorescence PCR for rapid prenatal detection of common chromosome abnormalities, including those responsible for Down syndrome, Edwards syndrome and Patau syndrome, the company said in a statement. The tests provide results within four hours, are validated and CE marked for in vitro diagnostic use in compliance with European Union regulations, and are suitable for both chronic villus and amniotic fluid analysis.